Development and validation of the short version of the Psychological General Well-Being Index (PGWB-S)

Enzo Grossi, Nicola Groth, Paola Mosconi, Renata Cerutti, Fabio Pace, Angelo Compare, Giovanni Apolone, Enzo Grossi, Nicola Groth, Paola Mosconi, Renata Cerutti, Fabio Pace, Angelo Compare, Giovanni Apolone

Abstract

Background: The PGWBI is a 22-item health-related Quality of Life (HRQoL) questionnaire developed in US which produces a self-perceived evaluation of psychological well-being expressed by a summary score. The PGWBI has been validated and used in many countries on large samples of the general population and on specific patient groups. Recently a study was carried out in Italy to reduce the number of items of the original questionnaire, yielding the creation of a shorter validated version of the questionnaire (PGWB-S). The purpose of the present paper is to describe the methods adopted and to report and discuss the relevance of results.

Methods: Data for this study were collected from 4 different population samples: two general population samples a student and a patient sample. On the basis of the results of the first (development) sample population, six relevant items were identified statistically from the original questionnaire and grouped to assemble a new summary scale. Following the newly created 6-item questionnaire was administered in three independent population samples. Descriptive statistics, correlation coefficients, univariate and multivariate regression analyses were used to compare the performance of the long and short questionnaire, within and between population samples and across relevant subgroups. A further independent sample extracted by an ongoing cancer clinical trial served as final validation step.

Results: Overall, the questionnaires were administered to 1443 subjects. Six items were selected by a step-wise approach to explain 90% of the variance of the summary measure of the original questionnaire. Response rates reached 100%, while missing items were not observed. University students (n = 400) showed the highest mean value of the summary measure (75.3); while the patient sample (n = 28) had the lowest score (71.5). The correlation coefficients between the summary measures and the single items according to the different studies were satisfactory, reaching the highest estimates in the student sample. The internal consistency showed high values of the Cronbach's alpha coefficient (range 0.80-0.92) for all three study samples, coming close to the value of the coefficient established for the original questionnaire (0.94). A cross-validation in an independent sample of 755 cancer patients confirmed the item selection procedure and amount of variance explained by the new shorter questionnaire (ranging from 90. 2 to 95.1 %, across age and sex strata).

Conclusion: The newly identified PGWB-S showed good acceptability and validity for the use in various settings in Italy. The translation of the PGWB-S into different languages, and its use in other linguistic settings will add evidence about its cross-cultural validity.

Figures

Figure 1
Figure 1
PGWBI short: items selection.

References

    1. Hunt SM, McKenna S. A British adaptation of the general Well-being Index: a new tool for clinical research. British J Med Economics. 1992;2:49–60.
    1. Bullinger M, Heinisch M, Ludwig M, Geier S. Skalen zur Erfassung des Wohlbefindens. Psychometrische Ueberpruefung des Profile of Mood States (POMS) und des Psychological General Well-Being Index (PGWBI) Z Differentielle Diagn Psychol. 1990;11:53–61.
    1. Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials: selecting quality of life measures. Controlled Clin Trials. 1991;12:S204–16. doi: 10.1016/S0197-2456(05)80024-8.
    1. Omvik P, Thaulow E, Herlan OB, Eide I, Midha R, Turner RR. Double-blind, parallel, comparative study on quality of life during treatment with amlodipine or enalapril in mild or moderate hypertensive patients: a multicenter study. J Hypertens. 1993;11:103–113. doi: 10.1097/00004872-199301000-00015.
    1. Walle PO, Westergren G, Dimenas E, Olofsson B, Albrektsen T. Effects of 100 mg of controlled-release metoprolol and 100 mg of atenolol on blood pressure, central nervous system-related symptoms, and general well being. J Clin Pharmacol. 1994;34:742–7.
    1. Rasmussen NA, Norholm V, Bech P. The internal and external validity of the Psychological General Well-Being Schedule (PGWB) Quality of Life News Letter. 1999;22:7.
    1. Wiklund I, Berg G, Hammar M, Karlberg J, Lindgren R, Sandin K. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas. 1992;14:225–36. doi: 10.1016/0378-5122(92)90117-M.
    1. Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, Lundell L, Pedersen SA, Carlsson R, Junghard O, Stubberod A, Anker-Hansen O. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol. 1999;94:1782–9. doi: 10.1111/j.1572-0241.1999.01206.x.
    1. Reddy P, White CM, Dunn AB, Moyna NM, Thompson PD. The effect of testosterone on health-related quality of life in elderly males – a pilot study. J Clin Pharm Ther. 2000;25:421–6. doi: 10.1046/j.1365-2710.2000.00309.x.
    1. Boman UW, Bryman I, Halling K, Moller A. Women with Turner syndrome: psychological well-being, self-rated health and social life. J Psychosom Obstet Gynaecol. 2001;22:113–22.
    1. Dupuy HJ. The Psychological General Well-being (PGWB) Index. In: Wenger NK, Mattson ME, Furburg CD, Elinson J, editor. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. New York. Le Jacq Publishing; 1984. pp. 170–83.
    1. Grossi E, Mosconi P, Groth N, Niero M, Apolone G. IL Questionario Psychological General Well Being. Questionario per la valutazione dello stato generale di benessere psicologico. Versione Italiana. Istituto di Ricerche Farmacologiche "Mario Negri", Milan. 2002.
    1. Groth N, Cerutti R, Rivolta G, Grossi E. Impact of transdermal estrogens treatment on postmenopausal symptoms and health-related quality of life: an Italian multicenter trial. J Hyg Prev Med. 2001;42:15–22.
    1. Apolone G, Mosconi P, Quattrociochi L, Gianicolo EAL, Groth N, Ware JE., Jr Questionario sullo stato di salute SF-12. Versione Italiana Guerini e Associati Editore, Milan. 2001.
    1. Kodraliu G, Mosconi P, Groth N, Carmosino GC, Donzelli A, Gianicolo E, Rossi C, Apolone G. Subjective health status assessment: evaluation of the Italian version of the SF-12 Health Survey. Results from the MiOS Project. J Epidemiol Biostatistics. 2001;6:305–16. doi: 10.1080/135952201317080715.
    1. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: Construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34:220–233. doi: 10.1097/00005650-199603000-00003.
    1. Gandek B, Ware JE, Aaronson NK, Apolone G, Bjorner JB, Brazier JE, Bullinger M, Kaasa S, Leplege A, Prieto L, Sullivan M. Cross-validation of item selection and scoring for the Sf-12 Health Survey in nine countries: Results from the IQOLA Project. J Clin Epidemiol. 1988;51:1171–1179. doi: 10.1016/S0895-4356(98)00109-7.
    1. McHorney CA, Ware JE, Lu JFR, Sherbourne CD. The MOS 36-Item Short-Form Health Survey (SF-36): III. Tests of data quality, scaling assumptions, and reliability across diverse patients groups. Med Care. 1994;32:40–66. doi: 10.1097/00005650-199401000-00004.
    1. Ware JE, Gandek B. Methods for testing data quality, scaling assumptions and reliability: The IQOLA Project approach. J Clin Epidemiol. 1988;51:945–952. doi: 10.1016/S0895-4356(98)00085-7.
    1. Stewart AL, Ware JE. Measuring functioning and well-being: The Medical Outcomes Study Approach. Durham, NC, Duke University Press; 1992.
    1. Aziz A, Bergquist C, Brannstrom M, Nordholm L, Silfverstolpe G. Differences in aspects of personality and sexuality between perimenopausal women making different choices regarding prophylactic oophorectomy at elective hysterectomy. Acta Obstet Gynecol Scand. 2005;84:854–9. doi: 10.1111/j.0001-6349.2005.00658.x.
    1. Mannion AF, Elfering A, Staerkle R, Junge A, Grob D, Semmer NK, Jacobshagen N, Dvorak J, Boos N. Outcome assessment in low back pain: how low can you go? Eur Spine J. 2005;14:1014–26. doi: 10.1007/s00586-005-0911-9.
    1. Wiklund I, Karlberg J, Mattsson L. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol. 1993;168:824–30.
    1. Wiklund I. Methods of assessing the impact of climacteric complaints on quality of life. Maturitas. 1998;29:41–50. doi: 10.1016/S0378-5122(98)00027-9.
    1. Wool C, Cerutti R, Marquis P, Ciadella P, Herviè C, ISGQL Psychometric validation of two Italian quality of life questionnaires in menopausal women. Maturitas. 2000;35:129–42. doi: 10.1016/S0378-5122(00)00093-1.
    1. Dimenas E, Carlsson G, Glise H, Israelsson B, Wiklund I. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl. 1996;221:8–13.
    1. Blomqvist A, Lonroth H, Dalenback J, Ruth M, Wiklund I, Lundell L. Quality of life assessment after laparoscopic and open fundoplications. Results of a prospective, clinical study. Scand J Gastroenterol. 1996;31:1052–8.
    1. Revicki DA, Crawley JA, Zodet MW, Levine DS, Joelsson BO. Complete resolution of heartburn symptoms and health-related quality of life in patients with gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 1999;13:1621–30. doi: 10.1046/j.1365-2036.1999.00669.x.
    1. Grossmann EM, Johnson FE, Virgo KS, Longo WE, Fossati R. Follow-up of colorectal cancer patients after resection with curative intent-the GILDA trial. Surg Oncol. 2004;13:119–24. doi: 10.1016/j.suronc.2004.08.005.

Source: PubMed

Sponzoři a spolupracovníci

Zdravotní podmínky

Drogové intervence

3
Předplatit